NervGen Pharma
Biotechnology Research • 
Vancouver, British Columbia, Canada • 11-20 Employees
Company overview
| Headquarters | 2955 Virtual Way, 480, Vancouver, British Columbia V5M 4X6, CA |
| Phone number | +18555596902 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Founded | 2018 |
| Employees | 11-20 |
| Socials |
Key Contacts at NervGen Pharma
Adam Rogers
Chief Executive Officer
Matthew Mcguinness
Senior Director, Corporate Controller
Marc Depaul
Director Of Research & Nvg-291 Project Leader
Judy Toews
Director, Pharmaceutical Development
Peng Zhou
Director Of Translational Research
Harold Punnett
Co-Founder
Harold Punnett
Director, Co-Founder
NervGen Pharma Email Formats
NervGen Pharma uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@nervgen.com), used 70% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@nervgen.com | 70% |
{first name}{last name} | johndoe@nervgen.com | 30% |
About NervGen Pharma
NervGen is a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to discovering and developing innovative treatments for nervous system damage, due to injury or disease. NervGen’s lead drug candidate, NVG-291, is a first of its kind experimental drug administered by injection under the skin. NVG-291 relieves the inhibitory effects of CSPGs and thus enables nervous system repair. In animal studies, this therapeutic approach promoted nervous system repair and enhanced recovery of functions such as walking, bladder control, vision, and memory. NVG-291 entered Phase 1 clinical trials in 2021. After completing our Phase 1 clinical trial, we plan to study the effectiveness and safety of NVG-291 initially in people with spinal cord injury, Alzheimer’s disease and multiple sclerosis.
NervGen Pharma revenue & valuation
| Annual revenue | $1,711,100 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
NervGen Pharma has 9 employees across 6 departments.
Departments
Number of employees
Funding Data
NervGen Pharma has never raised funding before.
NervGen Pharma Tech Stack
Discover the technologies and tools that power NervGen Pharma's digital infrastructure, from frameworks to analytics platforms.
Analytics
JavaScript libraries
Cookie compliance
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
Advertising
Font scripts
UI frameworks
France
United Arab Emirates
United Kingdom
North Macedonia
Finland
Malta
Ireland
Frequently asked questions
4.8
40,000 users
